Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2026-04-11 @ 9:44 AM
Study NCT ID:
NCT07233720
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2025-07-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Sponsor:
Henan Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
HNSZLYYNHL10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None